Ajanta Pharma Limited (NSE:AJANTPHARM) — Stock Price

Rs3506.20 INR
▲ 0.49% today

Ajanta Pharma Limited (NSE:AJANTPHARM) is currently trading at Rs3506.20 INR, up 0.49% today. Over the past 52 weeks, shares have ranged between Rs2388.40 and Rs3575.30. This page tracks Ajanta Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AJANTPHARM company net worth.

Ajanta Pharma Limited (AJANTPHARM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Ajanta Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Ajanta Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Ajanta Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs46.48 Billion Rs42.09 Billion Rs37.43 Billion Rs32.84 Billion Rs28.47 Billion
Cost of Revenue Rs10.71 Billion Rs11.15 Billion Rs11.10 Billion Rs8.87 Billion Rs6.82 Billion
Gross Profit Rs35.77 Billion Rs30.93 Billion Rs26.32 Billion Rs23.97 Billion Rs21.65 Billion
Research & Development Rs2.24 Billion Rs2.08 Billion Rs2.37 Billion Rs2.04 Billion Rs1.39 Billion
SG&A Rs10.99 Billion Rs1.30 Billion Rs7.93 Billion Rs6.52 Billion Rs384.00 Million
Total Operating Expenses Rs13.14 Billion Rs11.20 Billion Rs19.11 Billion Rs7.02 Billion Rs5.17 Billion
Operating Income Rs22.64 Billion Rs19.68 Billion Rs7.11 Billion Rs7.82 Billion Rs8.64 Billion
EBITDA Rs12.68 Billion Rs12.57 Billion Rs8.81 Billion Rs10.44 Billion Rs10.24 Billion
EBIT Rs11.24 Billion Rs11.21 Billion Rs7.51 Billion Rs9.20 Billion Rs9.08 Billion
Interest Expense Rs207.30 Million Rs72.10 Million Rs58.40 Million Rs102.00 Million Rs82.70 Million
Income Before Tax Rs11.89 Billion Rs11.14 Billion Rs7.45 Billion Rs9.09 Billion Rs9.00 Billion
Income Tax Expense Rs2.69 Billion Rs2.98 Billion Rs1.57 Billion Rs1.97 Billion Rs2.46 Billion
Net Income Rs9.20 Billion Rs8.16 Billion Rs5.88 Billion Rs7.13 Billion Rs6.54 Billion

Ajanta Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Ajanta Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs50.15 Billion Rs46.38 Billion Rs46.79 Billion Rs40.56 Billion Rs37.79 Billion
Total Current Assets Rs28.43 Billion Rs27.31 Billion Rs28.34 Billion Rs22.64 Billion Rs20.28 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs4.39 Billion Rs3.30 Billion Rs5.10 Billion Rs1.22 Billion Rs2.01 Billion
Net Receivables Rs11.83 Billion Rs12.47 Billion Rs10.57 Billion Rs10.20 Billion Rs7.38 Billion
Inventory Rs9.04 Billion Rs8.28 Billion Rs8.16 Billion Rs7.91 Billion Rs7.66 Billion
Property, Plant & Equipment Rs18.92 Billion Rs17.21 Billion Rs16.98 Billion Rs16.47 Billion Rs16.30 Billion
Goodwill — — — — —
Total Liabilities Rs12.25 Billion Rs10.71 Billion Rs12.91 Billion Rs7.91 Billion Rs7.83 Billion
Total Current Liabilities Rs9.96 Billion Rs8.96 Billion Rs11.39 Billion Rs6.47 Billion Rs6.49 Billion
Long-term Debt — Rs0.00 Rs12.50 Million Rs16.40 Million Rs16.00 Million
Net Debt Rs-1.29 Billion Rs-942.10 Million Rs-2.94 Billion Rs-1.81 Billion Rs-1.46 Billion
Total Stockholder Equity Rs37.90 Billion Rs35.67 Billion Rs33.88 Billion Rs32.64 Billion Rs29.96 Billion
Retained Earnings Rs36.72 Billion Rs33.14 Billion Rs31.41 Billion Rs27.18 Billion Rs21.56 Billion

Ajanta Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Ajanta Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs11.57 Billion Rs7.85 Billion Rs7.92 Billion Rs5.62 Billion Rs5.76 Billion
Capital Expenditures Rs3.18 Billion Rs1.52 Billion Rs1.74 Billion Rs1.49 Billion Rs1.72 Billion
Free Cash Flow Rs8.39 Billion Rs6.33 Billion Rs6.17 Billion Rs4.13 Billion Rs4.05 Billion
Investing Cash Flow Rs-3.77 Billion Rs653.90 Million Rs-5.60 Billion Rs-741.00 Million Rs-2.82 Billion
Financing Cash Flow Rs-7.33 Billion Rs-10.51 Billion Rs-1.08 Billion Rs-4.60 Billion Rs-3.18 Billion
Dividends Paid Rs3.49 Billion Rs6.42 Billion Rs896.90 Million Rs822.10 Million Rs829.00 Million
Stock-Based Compensation Rs38.80 Million Rs54.90 Million Rs2.20 Million Rs3.00 Million Rs200.00K
Depreciation Rs1.44 Billion Rs1.35 Billion Rs1.31 Billion Rs1.25 Billion Rs1.16 Billion
Change in Cash Rs460.10 Million Rs-2.01 Billion Rs1.24 Billion Rs279.00 Million Rs-243.60 Million

Ajanta Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Ajanta Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 28, 2026 — — —
Jan 30, 2026 21.91 19.84 +10.43%
Nov 03, 2025 20.82 21.65 -3.83%
Jul 28, 2025 20.43 20.90 -2.25%
Apr 30, 2025 18.00 16.90 +6.51%
Jan 30, 2025 18.59 16.42 +13.22%
Oct 28, 2024 17.26 18.07 -4.48%
Jul 30, 2024 19.53 17.60 +10.97%